IFNA1 and viral infectious disease: IFN, as an antiviral drug recommended by the guidelines, induces ISG transcription through the JAK/STAT pathway and targets to interfere with different stages of viral replication, including virus invasion, uncoating, gene recombination, and assembly machine release, acting as a resistance power in viral infection (15, 19–21).